Siga Technologies Stock Today
| SIGA Stock | USD 5.74 0.02 0.35% |
PerformanceVery Weak
| Odds Of DistressVery Small
|
SIGA Technologies is trading at 5.74 as of the 20th of March 2025, a 0.35 percent decrease since the beginning of the trading day. The stock's open price was 5.76. SIGA Technologies has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 20th of December 2024 and ending today, the 20th of March 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 9th of September 1997 | Category Healthcare | Classification Health Care |
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. The company was incorporated in 1995 and is headquartered in New York, New York. Siga Technologies operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. The company has 71.44 M outstanding shares of which 3.19 M shares are at this time shorted by private and institutional investors with about 8.92 trading days to cover. More on SIGA Technologies
Moving together with SIGA Stock
| 0.66 | A | Agilent Technologies | PairCorr |
| 0.84 | ME | 23Andme Holding | PairCorr |
| 0.73 | VANI | Vivani Medical Earnings Call This Week | PairCorr |
Moving against SIGA Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
SIGA Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO Director | Diem MBA | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Biotechnology, NASDAQ Composite, NASDAQ Health Care, Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsSIGA Technologies can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand SIGA Technologies' financial leverage. It provides some insight into what part of SIGA Technologies' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SIGA Technologies (SIGA) is traded on NASDAQ Exchange in USA. It is located in 31 East 62nd Street, New York, NY, United States, 10065 and employs 46 people. SIGA Technologies is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 411.48 M. SIGA Technologies conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 71.44 M outstanding shares of which 3.19 M shares are at this time shorted by private and institutional investors with about 8.92 trading days to cover.
SIGA Technologies currently holds about 114.53 M in cash with 48.76 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.57.
Check SIGA Technologies Probability Of Bankruptcy
Ownership AllocationSIGA Technologies shows a total of 71.44 Million outstanding shares. Over half of SIGA Technologies' outstanding shares are owned by institutional holders. These institutional holders are typically referred to as corporate investors that take positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check SIGA Ownership Details
SIGA Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Royce & Associates, Lp | 2024-12-31 | 844.3 K | |
| D. E. Shaw & Co Lp | 2024-12-31 | 592.7 K | |
| New York State Common Retirement Fund | 2024-12-31 | 589.6 K | |
| General American Investors Co Inc | 2024-12-31 | 539.7 K | |
| Legato Capital Management Llc | 2024-12-31 | 532.4 K | |
| Macquarie Group Ltd | 2024-12-31 | 528.7 K | |
| Uniplan Investment Counsel, Inc. | 2024-12-31 | 501 K | |
| Northern Trust Corp | 2024-12-31 | 464.8 K | |
| Charles Schwab Investment Management Inc | 2024-12-31 | 462.2 K | |
| Blackrock Inc | 2024-12-31 | 3.9 M | |
| Altravue Capital, Llc | 2024-12-31 | 2.6 M |
SIGA Technologies Historical Income Statement
SIGA Stock Against Markets
SIGA Technologies Corporate Management
| Jay MD | Chief VP | Profile | |
| Dennis Hruby | Chief Scientific Officer and VP | Profile | |
| Tove Bolken | Senior Officer | Profile | |
| Herb Vloedman | Senior Officer | Profile | |
| III MD | CEO Director | Profile | |
| JD Esq | General Counsel | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in SIGA Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. For information on how to trade SIGA Stock refer to our How to Trade SIGA Stock guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of SIGA Technologies. If investors know SIGA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about SIGA Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.37) | Earnings Share 0.82 | Revenue Per Share | Quarterly Revenue Growth (0.30) | Return On Assets |
The market value of SIGA Technologies is measured differently than its book value, which is the value of SIGA that is recorded on the company's balance sheet. Investors also form their own opinion of SIGA Technologies' value that differs from its market value or its book value, called intrinsic value, which is SIGA Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because SIGA Technologies' market value can be influenced by many factors that don't directly affect SIGA Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between SIGA Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if SIGA Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, SIGA Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.